Peptix  A-12 Bladder Peptide Bioregulator with Chitomur

Peptix A-12 Bladder Peptide Bioregulator with Chitomur

Brand: Firma Vita
SKU: EP-A12-60
55.00 USD In stock Buy at Merchant

Support Bladder Tissue at the Cellular Level Most urinary health supplements work around bladder tissue. Herbal extracts. Vitamins. Minerals. They create a better environment for the organ. None of them are a peptide bioregulator. Peptix A-12 with Chitomur is categorically different. It delivers peptide complex A-12 directly to bladder tissue. One active ingredient. One target tissue. That is the Khavinson framework applied to your urinary system. ✔ Supports healthy bladder tissue cells and normal urinary function* ✔ Helps maintain normal protein synthesis within bladder tissue* ✔ Supports normal bladder wall cell metabolism* ✔ Formulated with Khavinson peptide complex A-12 ✔ Sourced from bladder tissue of young animals using patented filtration technology ✔ 40+ years of published research from the St. Petersburg Institute of Bioregulation and Gerontology 🧬 Why Bladder Tissue Function Changes With Age Your bladder is a muscular organ. Its wall is made up of smooth muscle cells — the detrusor — layered with mucosal lining cells. Both depend on a consistent cycle of protein synthesis to maintain normal structure and function. As the body ages, peptide levels in organs and tissues decline. Bladder tissue is no different. When tissue-specific peptide signals fall, protein synthesis in those cells slows. The cells that maintain normal bladder wall structure and function become less efficient over time. That age-related cellular decline is exactly what most urinary supplements never address. They work around the organ. Peptix A-12 with Chitomur goes to the source: the bladder cells themselves. ⚙️ How Chitomur Works — The Cellular Mechanism Peptix A-12 with Chitomur is a dietary supplement formulated with peptide complex A-12. It is derived from the bladder tissue of young calves using patented filtration technology developed at the St. Petersburg Institute of Bioregulation and Gerontology. After absorption, the peptides are transported to bladder tissue via tissue-specific mechanisms. Once there, they act as cellular-level signaling molecules, supporting: Healthy activity in bladder wall cells and urinary tissue* Normal bladder tissue function and cellular metabolism* Normal protein synthesis within bladder tissue* Normal function within the broader urinary system* The mechanism is epigenetic. Based on articles retrieved from PubMed, short peptides bind complementarily to specific nucleotide sequences in DNA strands. That binding reduces the strength of proton bonds in the DNA double helix and stimulates gene transcription and replication. This is how tissue-specific protein synthesis is initiated and maintained at the cellular level. (Khavinson VKh et al. Epigenetic aspects of peptide regulation of aging. Adv Gerontol. 2012;25(1):11-22. PMID: 22708439) Bryan's Note: I have spent years going deep on the Khavinson research system. Over 800 peer-reviewed publications. Clinical studies confirmed across 40 years. The St. Petersburg Institute built this science from the ground up starting in the 1970s. Chitomur A-12 is one of the less talked about bioregulators in the Khavinson system. Most people building a urinary protocol know Pielotax for the kidneys and Vladonix for the thymus. What they miss is that the original Khavinson urinary system grouping specifically includes A-12 as the bladder piece. Kidneys filter. Bladder stores and releases. Two different organs. Two different peptide complexes. If you are building the full urinary protocol, Chitomur is the part that closes the system. That is not marketing. That is how the framework is structured. Bryan Rider, Founder, Rebel Peptides 🔬 The Research Behind Peptix A-12 with Chitomur Peptix A-12 with Chitomur belongs to the Khavinson Peptides system. Organ-specific peptide bioregulators developed at the Saint Petersburg Institute of Bioregulation and Gerontology. Dr. Vladimir Khavinson and his team have published over 800 peer-reviewed studies across more than 40 years of research. Geroprotective Mechanisms of Peptides — Khavinson and Malinin, 2002 Research published in the Bulletin of Experimental Biology and Medicine described the mechanisms underlying geroprotective effects of peptide bioregulators. The authors detailed how short peptides exert tissue-specific activity and support cellular protein synthesis, forming the scientific basis for the entire Khavinson bioregulator system. Read on PubMed Peptide Theory of Aging — Khavinson, 2002 A landmark review in Neuro Endocrinology Letters established that aging is driven by changes in gene expression resulting in reduced synthesis of tissue-specific peptides in organs. The proposed correction involves stimulating peptide production or delivering tissue-specific peptides directly. Clinical trials across multiple organ systems showed improvement in the conditions of respective organs. Read on PubMed 35 Years of Peptide Bioregulator Research — Khavinson and Anisimov, 2009 A review in Advances in Gerontology summarized 35 years of research on peptide bioregulator mechanisms and clinical efficacy across Russia, the US, the UK, Germany, Italy, Spain, and France. The molecular model described complementary interaction between short peptides and gene promoter sites as the basis for protein biosynthesis initiation. Read on PubMed Epigenetic Mechanism — Khavinson et al., 2012 Research in Advances in Gerontology confirmed that short endogenous peptides bind complementarily to specific DNA nucleotide sequences. That binding stimulates gene transcription and replication, underlining the tissue-specific protein synthesis activity observed across the Khavinson system. Read on PubMed This is peer-reviewed research. Published. Available on PubMed. The science behind Peptix A-12 with Chitomur is documented, not theoretical. 📖 Research Context — For Educational Reference Only The following describes the research context in which Khavinson bladder peptides have been studied. It is provided for educational purposes only. Peptix A-12 with Chitomur is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. Dr. Khavinson's research into bladder peptide bioregulators was conducted in the context of age-related decline in bladder tissue cell function and protein synthesis. The research explored how peptide bioregulator supplementation may support the maintenance of normal bladder wall cell metabolism and urinary tissue protein synthesis during aging. None of this constitutes a basis for claiming that Peptix A-12 with Chitomur treats, reduces, or prevents any urinary disease or condition. Always consult your doctor before taking this product, especially if you have an existing urinary health concern or take prescription medication. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. BENEFITS Formulated with Khavinson peptide complex A-12 — the bladder tissue peptide bioregulator* Supports healthy bladder cells and normal urinary tissue function at the cellular level* Sourced from bladder tissue of young animals using patented filtration technology Supports normal bladder wall cell metabolism and cellular protein synthesis* Non-immunogenic formulation — molecular weight under 5 kDa, free from foreign DNA or protein substance Available in 60 capsules (30-day supply) and 20 capsules (10-day course) Ships from USA warehouse — ready to ship within 2 business days

Specifications
Size
60 Caps (30 day supply), 20 Caps (10 day supply)
Variants (2)
  • 60 Caps (30 day supply) — 135.00 USD — In stock
  • 20 Caps (10 day supply) — 55.00 USD — In stock

How AI sees this product

The more complete this product's details, the more confidently AI assistants can understand and recommend it.

89%